MétaCan
Menu
Back to cohort
Record W4409241925 · doi:10.4212/cjhp.3631

Analyse des risques, par la méthode AMDEC, du circuit de contrôle des médicaments dangereux

2025· article· fr· W4409241925 on OpenAlexvenueno aff
Fatih Kara, Yassine Mokni, Sarra Ouertani, E.O. Amira, S. Sebai, Kaouther Zribi

Bibliographic record

VenueThe Canadian Journal of Hospital Pharmacy · 2025
Typearticle
Languagefr
FieldHealth Professions
TopicSafe Handling of Antineoplastic Drugs
Canadian institutionsnot available
Fundersnot available
KeywordsGynecologyMedicinePolitical science

Abstract

fetched live from OpenAlex

Contexte : La gestion des risques s’inscrit dans le programme d’amélioration de la qualité et de la sécurité de la prise en charge médicamenteuse. Objectifs : Cartographier le processus de contrôle des médicaments dangereux (MD), évaluer les risques du circuit de contrôle et définir les actions correctives à mettre en place pour sécuriser le circuit au sein d’un laboratoire de contrôle des médicaments. Méthodologie : Une étude analytique a été réalisée, sur une période de 6 mois, dans le Laboratoire National du Contrôle des Médicaments en Tunisie. L’analyse des risques a été réalisée par la méthode AMDEC (analyse des modes de défaillance, de leurs effets et de leur criticité). Résultats : Au total, 53 modes de défaillance et 3 niveaux de criticité ont été détectés en utilisant le diagramme d’Ishikawa et la méthode des 5M (matière, milieu, méthode, matériel, main d’œuvre).Trente-trois étaient de criticité majeure, 14 de criticité modérée et 6 de criticité mineure. Le contrôle des MD est donc un processus de criticité importante (Cmoy : 31,9), ce qui a imposé la mise en place d’un plan d’action efficace afin de réduire le niveau de criticité à faible (Cmoy : 10,4). Conclusion : Le processus de contrôle des MD était complexe et était associé à un niveau de risque élevé. Après analyse des causes possibles et des obstacles préexistants, un plan d’action a été élaboré. Le suivi des actions reste primordial à la maîtrise de ce processus. Un département spécialisé est à envisager en cas d’augmentation de l’activité, notamment avec l’arrivée des thérapies innovantes qui nécessitent plus de restrictions au cours de la manipulation. Mots clés : analyse des risques, sécurisation, contrôle, médicaments dangereux, analyse des modes de défaillance, de leurs effets et de leur criticité, AMDEC ABSTRACT Background: Risk management is one aspect of improving the quality and safety of medication care. Objectives: To map the process of monitoring hazardous drugs, assess the risks of the monitoring cycle and identify corrective actions to be implemented to ensure the safety of the cycle within a drug monitoring laboratory. Methods: An analytical study was conducted over a period of 6 months in Tunisia’s national drug monitoring laboratory. The risk analysis was carried out using the failure modes and effects analysis (FMEA) method. Results: A total of 53 failure modes and 3 critical levels were detected using the Ishikawa diagram and the 5M method (equipment environment, methods, materials, workforce). Thirty-three of the failure modes were of major criticality, 14 of moderate criticality and 6 of minor criticality. Overall, hazardous drug monitoring was found to be a high criticality (Cavg: 31.9) process, which required the implementation of an effective action plan in order to reduce the level of criticality to minor (Cavg: 10.4). Conclusion: The hazardous drug monitoring process was complex and was associated with a high level of risk. After analyzing possible causes and pre-existing obstacles, an action plan was developed. Monitoring the elements of the action plan remains essential to controlling this process. A specialized department may be considered in the event of an increase in activity, for example with the surge of innovative therapies that require more restrictions during handling. Keywords: risk analysis, safety, monitoring, hazardous drugs, failure modes and effects analysis, FMEA

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.005
metaresearch head score (Gemma)0.003
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Science and technology studies, Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.285
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0050.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.001
Science and technology studies0.0020.002
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.002
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.058
GPT teacher head0.371
Teacher spread0.312 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueThe Canadian Journal of Hospital PharmacySame topicSafe Handling of Antineoplastic DrugsFrench-language works237,207